Healio (9/13, Bascom) reports, “Mothers in Greece who strongly adhered to a Mediterranean diet had a significantly reduced risk for postpartum depression,” according to the findings of a 3,491-postpartum woman study published online Sept. 4 in the journal Nutrients. Investigators assessed “postpartum depression with the Edinburgh Postnatal Depression Scale and adherence to the Mediterranean diet with the MedDietScore.”

Related Links:

— “Mediterranean diet may reduce postpartum depression,”Emma Bascom, Healio, September 13, 2023

KFF Health News (9/13, Saint Louis) reports, “Family-based residential treatment” for addiction “has been recognized by behavioral health professionals as having better outcomes for women and their children,” but these “programs often struggle to stay afloat because of staffing shortages and volatile funding.” As a result, “families in rural areas are less likely to find such a residential treatment program in their communities.”

Related Links:

— “Despite Successes, Addiction Treatment Programs for Families Struggle to Stay Open,”Christina Saint Louis, KFF Health News, September 13, 2023

HealthDay (9/13, Reinberg) reports, “Using both tobacco and marijuana is tied to significantly higher odds for depression and anxiety,” according to findings published online Sept. 13 in the journal PLOS One. After collecting “data on 53,843 adults who participated in online surveys as part of the COVID-19 Citizen Science Study from 2020 to 2022,” researchers found that “those who used both substances experienced anxiety or depression at nearly twice the rate of nonusers.” Healio (9/13, Rhoades) also covers the study.

Related Links:

— “Depression Risk Rises in Folks Who Use Both Marijuana & Tobacco,”Steven Reinberg, HealthDay, September 13, 2023

The Washington Post (9/12, A1, Rich, Ovalle) reports, “The number of prescription opioid pain pills shipped in the United States plummeted nearly 45% between 2011 and 2019, new federal data shows, even as fatal overdoses rose to record levels as users increasingly used heroin, and then illegal fentanyl.” This indicates “users first got hooked by pain pills saturating the nation, then turned to cheaper and more readily available street drugs after law-enforcement crackdowns, public outcry and changes in how the medical community views prescribing opioids to treat pain.” In 2011, “the number of prescription hydrocodone and oxycodone pills peaked…at 12.8 billion pills,” then “dropped to less than 7.1 billion by 2019.” The only prescription opioid that saw increased use in this time period was buprenorphine, which is used to treat opioid addiction, increasing “from 42 million doses in 2006 to 577 million in 2019.”

The AP (9/12, Mulvihill) reports, “The fentanyl-driven crisis is more deadly than any other drug tragedy the nation has ever seen. In 2010, opioids were linked to just over 21,000 deaths in the U.S. In 2022, the opioid-related death toll was more than 82,000.”

Related Links:

— “The Washington Post (requires login and subscription)

MedPage Today (9/12, Monaco) reports, “Care for new depression was more commonly delivered by primary care providers (PCPs) than psychiatric” clinicians, investigators concluded in findings presented in a poster at Psych Congress 2023. The “review of adults newly diagnosed with major depressive disorder, 16,987 patients were under the care of a PCP compared with 1,780 who were managed by a psychiatrist at the time of diagnosis, and only 6.2% of PCP-managed patients transitioned to a psychiatrist for their care,” the study found.

Related Links:

— MedPage Today (requires login and subscription)